Spring til hovednavigation
Spring til søgning
Spring til hovedindhold
Københavns Universitets forskningsportal Forside
Hjælp og OSS
Dansk
English
Forside
Profiler
Publikation
Forskningsenheder
Presse/medier
Aktiviteter
Priser
???studenttheses???
Forskningsdatasæt
Søg efter ekspertise, navn eller tilknytning
Comparative review of dipeptidyl peptidase-4 inhibitors and sulphonylureas.
Carolyn F. Deacon
, HE Lebovitz
Endocrinology and Metabolism
115
Citationer (Scopus)
Oversigt
Fingeraftryk
Fingeraftryk
Dyk ned i forskningsemnerne om 'Comparative review of dipeptidyl peptidase-4 inhibitors and sulphonylureas.'. Sammen danner de et unikt fingeraftryk.
Sorter
Vægt
Alfabetisk
Keyphrases
Adverse Effects
16%
Cardiovascular Risk
16%
Dipeptidyl peptidase-4 (DPP-4)
100%
Drug Class
16%
Glycemic Control
50%
Hypoglycemia
16%
Hypoglycemia Risk
16%
Metformin
16%
Metformin Monotherapy
16%
Oral Antidiabetic Drugs
16%
Pharmacotherapy
16%
Progressive Disease
16%
Safety Trial
16%
Second-line Agents
16%
Sulfonylurea
100%
Treatment Algorithm
16%
Type 2 Diabetes Mellitus (T2DM)
33%
Weight Gain
33%
Medicine and Dentistry
Cardiovascular Risk
16%
Dipeptidyl Peptidase-4 Inhibitor
100%
Drug Therapy
16%
Glycemic Control
50%
Glycon
33%
Hypoglycemia
33%
Maturity Onset Diabetes of the Young
16%
Monotherapy
16%
Oral Antidiabetic Agent
16%
Progressive Disease
16%
Side Effect
33%
Sulfonylurea
100%
Type 2 Diabetes
33%
Nursing and Health Professions
Cardiovascular Risk
16%
Dipeptidyl Peptidase IV Inhibitor
100%
Diseases
16%
Drug Therapy
16%
Hypoglycemia
33%
Metformin
33%
Monotherapy
16%
Non Insulin Dependent Diabetes Mellitus
16%
Oral Antidiabetic Agent
16%
Side Effect
33%
Sulfonylurea
100%
Pharmacology, Toxicology and Pharmaceutical Science
Cardiovascular Risk
16%
Dipeptidyl Peptidase IV Inhibitor
100%
Diseases
16%
Hypoglycemia
33%
Metformin
33%
Monotherapy
16%
Non Insulin Dependent Diabetes Mellitus
16%
Oral Antidiabetic Agent
16%
Pharmacotherapy
16%
Side Effect
33%
Sulfonylurea
100%